Telcon RF Pharmaceutical Inc
KOSDAQ:200230
Telcon RF Pharmaceutical Inc
Intangible Assets
Telcon RF Pharmaceutical Inc
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
Telcon RF Pharmaceutical Inc
KOSDAQ:200230
|
Intangible Assets
₩16.9B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
51%
|
|
|
D
|
DreamTech Co Ltd
KRX:192650
|
Intangible Assets
₩15.3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
K
|
KH Electron Co Ltd
KOSDAQ:111870
|
Intangible Assets
₩3.1B
|
CAGR 3-Years
24%
|
CAGR 5-Years
14%
|
CAGR 10-Years
11%
|
|
|
P
|
Pavonine Co Ltd
KOSDAQ:177830
|
Intangible Assets
₩2.3B
|
CAGR 3-Years
140%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
18%
|
|
|
P
|
PJ Electronics Co Ltd
KOSDAQ:006140
|
Intangible Assets
₩1.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
63%
|
CAGR 10-Years
19%
|
|
Telcon RF Pharmaceutical Inc
Glance View
TELCON RF PHARMACEUTICAL.Inc. engages in the manufacture, development and sale of cable assemblies and medicinal products. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2014-11-24. Inc., formerly TELCON.Inc, is a Korea-based company principally engaged in the manufacture and distribution of connectors and cable assemblies. The Company’s products mainly consist of radio frequency (RF) connectors, RF cables, couplers, dividers, arrestors, terminations, adapters, and other cable assemblies, which are used for wireless communication equipment.
See Also
What is Telcon RF Pharmaceutical Inc's Intangible Assets?
Intangible Assets
16.9B
KRW
Based on the financial report for Sep 30, 2025, Telcon RF Pharmaceutical Inc's Intangible Assets amounts to 16.9B KRW.
What is Telcon RF Pharmaceutical Inc's Intangible Assets growth rate?
Intangible Assets CAGR 10Y
51%
Over the last year, the Intangible Assets growth was -13%. The average annual Intangible Assets growth rates for Telcon RF Pharmaceutical Inc have been -16% over the past three years , -11% over the past five years , and 51% over the past ten years .
